Q98127346

Summary

Q98127346 is a bill^[1].

Key Facts

• Q98127346's instance of is recorded as bill^[2].
• Q98127346's part of the series is recorded as propositions of the 2011-2012 legislative session of the Riksdag^[3].
• Q98127346's language of work or name is recorded as Swedish^[4].
• Q98127346 was published on +2012-02-21T00:00:00Z^[5].
• Q98127346's main subject is medication^[6].
• Q98127346's work available at URL is recorded as http://data.riksdagen.se/dokument/GZ0374^[7].
• Q98127346's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GZ0374^[8].
• Q98127346's work available at URL is recorded as http://data.riksdagen.se/fil/B73596B5-1BD8-4331-B95E-7E195E3966AC^[9].
• Q98127346's applies to jurisdiction is recorded as Sweden^[10].
• Q98127346's legal citation of this text is recorded as Prop. 2011/12:74^[11].
• Q98127346's title is recorded as Genomförande av ändringsdirektiv 2010/84/EU avseende säkerhetsövervakning av läkemedel^[12].
• Q98127346's cites work is recorded as Q98138279^[13].
• Q98127346's cites work is recorded as Q98143494^[14].
• Q98127346's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98127346's copyright status is recorded as public domain^[16].
• Q98127346's legislative committee is recorded as Committee on Health and Welfare^[17].

Body

Definition and Type

Q98127346's instance of is recorded as bill^[2].